Global Bio-active Peptides Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Bio-active peptides are organic substances formed by amino acids joined by covalent bonds known as amide or peptide bonds. Although some BP exist free in its natural source, the vast majority of known BP are encrypted in the structure of the parent proteins and are released mainly by enzymatic processes.
According to our (Global Info Research) latest study, the global Bio-active Peptides market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Bio-active Peptides market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Bio-active Peptides market size and forecasts, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2018-2029
Global Bio-active Peptides market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2018-2029
Global Bio-active Peptides market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2018-2029
Global Bio-active Peptides market shares of main players, shipments in revenue ($ Million), sales quantity (Ton), and ASP (US$/Ton), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Bio-active Peptides
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Bio-active Peptides market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Archer Daniels Midland Company, Seagarden AS, Phermpep, Arlak Biotech and Naturade, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Bio-active Peptides market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Bio-active Peptides product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Bio-active Peptides, with price, sales, revenue and global market share of Bio-active Peptides from 2018 to 2023.
Chapter 3, the Bio-active Peptides competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bio-active Peptides breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Bio-active Peptides market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Bio-active Peptides.
Chapter 14 and 15, to describe Bio-active Peptides sales channel, distributors, customers, research findings and conclusion.
According to our (Global Info Research) latest study, the global Bio-active Peptides market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Bio-active Peptides market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Bio-active Peptides market size and forecasts, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2018-2029
Global Bio-active Peptides market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2018-2029
Global Bio-active Peptides market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2018-2029
Global Bio-active Peptides market shares of main players, shipments in revenue ($ Million), sales quantity (Ton), and ASP (US$/Ton), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Bio-active Peptides
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Bio-active Peptides market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Archer Daniels Midland Company, Seagarden AS, Phermpep, Arlak Biotech and Naturade, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Bio-active Peptides market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Natural Bio-active Peptides
- Artificial Synthesis Bio-active Peptides
- Food
- Health Products
- Pharmaceutical
- Other
- Archer Daniels Midland Company
- Seagarden AS
- Phermpep
- Arlak Biotech
- Naturade
- Royal DSM
- MYOS RENS Technology
- Natural Factors Nutritional Products
- Valio Oy
- Wuhan Lullaby Pharmaceutical Chemical
- Wuhan Dahua Pharmaceutical
- Pharma Foods International
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Bio-active Peptides product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Bio-active Peptides, with price, sales, revenue and global market share of Bio-active Peptides from 2018 to 2023.
Chapter 3, the Bio-active Peptides competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bio-active Peptides breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Bio-active Peptides market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Bio-active Peptides.
Chapter 14 and 15, to describe Bio-active Peptides sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Bio-active Peptides
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Bio-active Peptides Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Natural Bio-active Peptides
1.3.3 Artificial Synthesis Bio-active Peptides
1.4 Market Analysis by Application
1.4.1 Overview: Global Bio-active Peptides Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Food
1.4.3 Health Products
1.4.4 Pharmaceutical
1.4.5 Other
1.5 Global Bio-active Peptides Market Size & Forecast
1.5.1 Global Bio-active Peptides Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Bio-active Peptides Sales Quantity (2018-2029)
1.5.3 Global Bio-active Peptides Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Archer Daniels Midland Company
2.1.1 Archer Daniels Midland Company Details
2.1.2 Archer Daniels Midland Company Major Business
2.1.3 Archer Daniels Midland Company Bio-active Peptides Product and Services
2.1.4 Archer Daniels Midland Company Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Archer Daniels Midland Company Recent Developments/Updates
2.2 Seagarden AS
2.2.1 Seagarden AS Details
2.2.2 Seagarden AS Major Business
2.2.3 Seagarden AS Bio-active Peptides Product and Services
2.2.4 Seagarden AS Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Seagarden AS Recent Developments/Updates
2.3 Phermpep
2.3.1 Phermpep Details
2.3.2 Phermpep Major Business
2.3.3 Phermpep Bio-active Peptides Product and Services
2.3.4 Phermpep Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Phermpep Recent Developments/Updates
2.4 Arlak Biotech
2.4.1 Arlak Biotech Details
2.4.2 Arlak Biotech Major Business
2.4.3 Arlak Biotech Bio-active Peptides Product and Services
2.4.4 Arlak Biotech Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Arlak Biotech Recent Developments/Updates
2.5 Naturade
2.5.1 Naturade Details
2.5.2 Naturade Major Business
2.5.3 Naturade Bio-active Peptides Product and Services
2.5.4 Naturade Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Naturade Recent Developments/Updates
2.6 Royal DSM
2.6.1 Royal DSM Details
2.6.2 Royal DSM Major Business
2.6.3 Royal DSM Bio-active Peptides Product and Services
2.6.4 Royal DSM Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Royal DSM Recent Developments/Updates
2.7 MYOS RENS Technology
2.7.1 MYOS RENS Technology Details
2.7.2 MYOS RENS Technology Major Business
2.7.3 MYOS RENS Technology Bio-active Peptides Product and Services
2.7.4 MYOS RENS Technology Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 MYOS RENS Technology Recent Developments/Updates
2.8 Natural Factors Nutritional Products
2.8.1 Natural Factors Nutritional Products Details
2.8.2 Natural Factors Nutritional Products Major Business
2.8.3 Natural Factors Nutritional Products Bio-active Peptides Product and Services
2.8.4 Natural Factors Nutritional Products Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Natural Factors Nutritional Products Recent Developments/Updates
2.9 Valio Oy
2.9.1 Valio Oy Details
2.9.2 Valio Oy Major Business
2.9.3 Valio Oy Bio-active Peptides Product and Services
2.9.4 Valio Oy Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Valio Oy Recent Developments/Updates
2.10 Wuhan Lullaby Pharmaceutical Chemical
2.10.1 Wuhan Lullaby Pharmaceutical Chemical Details
2.10.2 Wuhan Lullaby Pharmaceutical Chemical Major Business
2.10.3 Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Product and Services
2.10.4 Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Wuhan Lullaby Pharmaceutical Chemical Recent Developments/Updates
2.11 Wuhan Dahua Pharmaceutical
2.11.1 Wuhan Dahua Pharmaceutical Details
2.11.2 Wuhan Dahua Pharmaceutical Major Business
2.11.3 Wuhan Dahua Pharmaceutical Bio-active Peptides Product and Services
2.11.4 Wuhan Dahua Pharmaceutical Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Wuhan Dahua Pharmaceutical Recent Developments/Updates
2.12 Pharma Foods International
2.12.1 Pharma Foods International Details
2.12.2 Pharma Foods International Major Business
2.12.3 Pharma Foods International Bio-active Peptides Product and Services
2.12.4 Pharma Foods International Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Pharma Foods International Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BIO-ACTIVE PEPTIDES BY MANUFACTURER
3.1 Global Bio-active Peptides Sales Quantity by Manufacturer (2018-2023)
3.2 Global Bio-active Peptides Revenue by Manufacturer (2018-2023)
3.3 Global Bio-active Peptides Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Bio-active Peptides by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Bio-active Peptides Manufacturer Market Share in 2022
3.4.2 Top 6 Bio-active Peptides Manufacturer Market Share in 2022
3.5 Bio-active Peptides Market: Overall Company Footprint Analysis
3.5.1 Bio-active Peptides Market: Region Footprint
3.5.2 Bio-active Peptides Market: Company Product Type Footprint
3.5.3 Bio-active Peptides Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Bio-active Peptides Market Size by Region
4.1.1 Global Bio-active Peptides Sales Quantity by Region (2018-2029)
4.1.2 Global Bio-active Peptides Consumption Value by Region (2018-2029)
4.1.3 Global Bio-active Peptides Average Price by Region (2018-2029)
4.2 North America Bio-active Peptides Consumption Value (2018-2029)
4.3 Europe Bio-active Peptides Consumption Value (2018-2029)
4.4 Asia-Pacific Bio-active Peptides Consumption Value (2018-2029)
4.5 South America Bio-active Peptides Consumption Value (2018-2029)
4.6 Middle East and Africa Bio-active Peptides Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Bio-active Peptides Sales Quantity by Type (2018-2029)
5.2 Global Bio-active Peptides Consumption Value by Type (2018-2029)
5.3 Global Bio-active Peptides Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Bio-active Peptides Sales Quantity by Application (2018-2029)
6.2 Global Bio-active Peptides Consumption Value by Application (2018-2029)
6.3 Global Bio-active Peptides Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Bio-active Peptides Sales Quantity by Type (2018-2029)
7.2 North America Bio-active Peptides Sales Quantity by Application (2018-2029)
7.3 North America Bio-active Peptides Market Size by Country
7.3.1 North America Bio-active Peptides Sales Quantity by Country (2018-2029)
7.3.2 North America Bio-active Peptides Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Bio-active Peptides Sales Quantity by Type (2018-2029)
8.2 Europe Bio-active Peptides Sales Quantity by Application (2018-2029)
8.3 Europe Bio-active Peptides Market Size by Country
8.3.1 Europe Bio-active Peptides Sales Quantity by Country (2018-2029)
8.3.2 Europe Bio-active Peptides Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Bio-active Peptides Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Bio-active Peptides Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Bio-active Peptides Market Size by Region
9.3.1 Asia-Pacific Bio-active Peptides Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Bio-active Peptides Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Bio-active Peptides Sales Quantity by Type (2018-2029)
10.2 South America Bio-active Peptides Sales Quantity by Application (2018-2029)
10.3 South America Bio-active Peptides Market Size by Country
10.3.1 South America Bio-active Peptides Sales Quantity by Country (2018-2029)
10.3.2 South America Bio-active Peptides Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Bio-active Peptides Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Bio-active Peptides Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Bio-active Peptides Market Size by Country
11.3.1 Middle East & Africa Bio-active Peptides Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Bio-active Peptides Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Bio-active Peptides Market Drivers
12.2 Bio-active Peptides Market Restraints
12.3 Bio-active Peptides Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Bio-active Peptides and Key Manufacturers
13.2 Manufacturing Costs Percentage of Bio-active Peptides
13.3 Bio-active Peptides Production Process
13.4 Bio-active Peptides Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Bio-active Peptides Typical Distributors
14.3 Bio-active Peptides Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Bio-active Peptides
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Bio-active Peptides Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Natural Bio-active Peptides
1.3.3 Artificial Synthesis Bio-active Peptides
1.4 Market Analysis by Application
1.4.1 Overview: Global Bio-active Peptides Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Food
1.4.3 Health Products
1.4.4 Pharmaceutical
1.4.5 Other
1.5 Global Bio-active Peptides Market Size & Forecast
1.5.1 Global Bio-active Peptides Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Bio-active Peptides Sales Quantity (2018-2029)
1.5.3 Global Bio-active Peptides Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Archer Daniels Midland Company
2.1.1 Archer Daniels Midland Company Details
2.1.2 Archer Daniels Midland Company Major Business
2.1.3 Archer Daniels Midland Company Bio-active Peptides Product and Services
2.1.4 Archer Daniels Midland Company Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Archer Daniels Midland Company Recent Developments/Updates
2.2 Seagarden AS
2.2.1 Seagarden AS Details
2.2.2 Seagarden AS Major Business
2.2.3 Seagarden AS Bio-active Peptides Product and Services
2.2.4 Seagarden AS Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Seagarden AS Recent Developments/Updates
2.3 Phermpep
2.3.1 Phermpep Details
2.3.2 Phermpep Major Business
2.3.3 Phermpep Bio-active Peptides Product and Services
2.3.4 Phermpep Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Phermpep Recent Developments/Updates
2.4 Arlak Biotech
2.4.1 Arlak Biotech Details
2.4.2 Arlak Biotech Major Business
2.4.3 Arlak Biotech Bio-active Peptides Product and Services
2.4.4 Arlak Biotech Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Arlak Biotech Recent Developments/Updates
2.5 Naturade
2.5.1 Naturade Details
2.5.2 Naturade Major Business
2.5.3 Naturade Bio-active Peptides Product and Services
2.5.4 Naturade Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Naturade Recent Developments/Updates
2.6 Royal DSM
2.6.1 Royal DSM Details
2.6.2 Royal DSM Major Business
2.6.3 Royal DSM Bio-active Peptides Product and Services
2.6.4 Royal DSM Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Royal DSM Recent Developments/Updates
2.7 MYOS RENS Technology
2.7.1 MYOS RENS Technology Details
2.7.2 MYOS RENS Technology Major Business
2.7.3 MYOS RENS Technology Bio-active Peptides Product and Services
2.7.4 MYOS RENS Technology Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 MYOS RENS Technology Recent Developments/Updates
2.8 Natural Factors Nutritional Products
2.8.1 Natural Factors Nutritional Products Details
2.8.2 Natural Factors Nutritional Products Major Business
2.8.3 Natural Factors Nutritional Products Bio-active Peptides Product and Services
2.8.4 Natural Factors Nutritional Products Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Natural Factors Nutritional Products Recent Developments/Updates
2.9 Valio Oy
2.9.1 Valio Oy Details
2.9.2 Valio Oy Major Business
2.9.3 Valio Oy Bio-active Peptides Product and Services
2.9.4 Valio Oy Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Valio Oy Recent Developments/Updates
2.10 Wuhan Lullaby Pharmaceutical Chemical
2.10.1 Wuhan Lullaby Pharmaceutical Chemical Details
2.10.2 Wuhan Lullaby Pharmaceutical Chemical Major Business
2.10.3 Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Product and Services
2.10.4 Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Wuhan Lullaby Pharmaceutical Chemical Recent Developments/Updates
2.11 Wuhan Dahua Pharmaceutical
2.11.1 Wuhan Dahua Pharmaceutical Details
2.11.2 Wuhan Dahua Pharmaceutical Major Business
2.11.3 Wuhan Dahua Pharmaceutical Bio-active Peptides Product and Services
2.11.4 Wuhan Dahua Pharmaceutical Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Wuhan Dahua Pharmaceutical Recent Developments/Updates
2.12 Pharma Foods International
2.12.1 Pharma Foods International Details
2.12.2 Pharma Foods International Major Business
2.12.3 Pharma Foods International Bio-active Peptides Product and Services
2.12.4 Pharma Foods International Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Pharma Foods International Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BIO-ACTIVE PEPTIDES BY MANUFACTURER
3.1 Global Bio-active Peptides Sales Quantity by Manufacturer (2018-2023)
3.2 Global Bio-active Peptides Revenue by Manufacturer (2018-2023)
3.3 Global Bio-active Peptides Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Bio-active Peptides by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Bio-active Peptides Manufacturer Market Share in 2022
3.4.2 Top 6 Bio-active Peptides Manufacturer Market Share in 2022
3.5 Bio-active Peptides Market: Overall Company Footprint Analysis
3.5.1 Bio-active Peptides Market: Region Footprint
3.5.2 Bio-active Peptides Market: Company Product Type Footprint
3.5.3 Bio-active Peptides Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Bio-active Peptides Market Size by Region
4.1.1 Global Bio-active Peptides Sales Quantity by Region (2018-2029)
4.1.2 Global Bio-active Peptides Consumption Value by Region (2018-2029)
4.1.3 Global Bio-active Peptides Average Price by Region (2018-2029)
4.2 North America Bio-active Peptides Consumption Value (2018-2029)
4.3 Europe Bio-active Peptides Consumption Value (2018-2029)
4.4 Asia-Pacific Bio-active Peptides Consumption Value (2018-2029)
4.5 South America Bio-active Peptides Consumption Value (2018-2029)
4.6 Middle East and Africa Bio-active Peptides Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Bio-active Peptides Sales Quantity by Type (2018-2029)
5.2 Global Bio-active Peptides Consumption Value by Type (2018-2029)
5.3 Global Bio-active Peptides Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Bio-active Peptides Sales Quantity by Application (2018-2029)
6.2 Global Bio-active Peptides Consumption Value by Application (2018-2029)
6.3 Global Bio-active Peptides Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Bio-active Peptides Sales Quantity by Type (2018-2029)
7.2 North America Bio-active Peptides Sales Quantity by Application (2018-2029)
7.3 North America Bio-active Peptides Market Size by Country
7.3.1 North America Bio-active Peptides Sales Quantity by Country (2018-2029)
7.3.2 North America Bio-active Peptides Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Bio-active Peptides Sales Quantity by Type (2018-2029)
8.2 Europe Bio-active Peptides Sales Quantity by Application (2018-2029)
8.3 Europe Bio-active Peptides Market Size by Country
8.3.1 Europe Bio-active Peptides Sales Quantity by Country (2018-2029)
8.3.2 Europe Bio-active Peptides Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Bio-active Peptides Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Bio-active Peptides Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Bio-active Peptides Market Size by Region
9.3.1 Asia-Pacific Bio-active Peptides Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Bio-active Peptides Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Bio-active Peptides Sales Quantity by Type (2018-2029)
10.2 South America Bio-active Peptides Sales Quantity by Application (2018-2029)
10.3 South America Bio-active Peptides Market Size by Country
10.3.1 South America Bio-active Peptides Sales Quantity by Country (2018-2029)
10.3.2 South America Bio-active Peptides Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Bio-active Peptides Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Bio-active Peptides Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Bio-active Peptides Market Size by Country
11.3.1 Middle East & Africa Bio-active Peptides Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Bio-active Peptides Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Bio-active Peptides Market Drivers
12.2 Bio-active Peptides Market Restraints
12.3 Bio-active Peptides Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Bio-active Peptides and Key Manufacturers
13.2 Manufacturing Costs Percentage of Bio-active Peptides
13.3 Bio-active Peptides Production Process
13.4 Bio-active Peptides Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Bio-active Peptides Typical Distributors
14.3 Bio-active Peptides Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Bio-active Peptides Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Bio-active Peptides Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Archer Daniels Midland Company Basic Information, Manufacturing Base and Competitors
Table 4. Archer Daniels Midland Company Major Business
Table 5. Archer Daniels Midland Company Bio-active Peptides Product and Services
Table 6. Archer Daniels Midland Company Bio-active Peptides Sales Quantity (Ton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Archer Daniels Midland Company Recent Developments/Updates
Table 8. Seagarden AS Basic Information, Manufacturing Base and Competitors
Table 9. Seagarden AS Major Business
Table 10. Seagarden AS Bio-active Peptides Product and Services
Table 11. Seagarden AS Bio-active Peptides Sales Quantity (Ton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Seagarden AS Recent Developments/Updates
Table 13. Phermpep Basic Information, Manufacturing Base and Competitors
Table 14. Phermpep Major Business
Table 15. Phermpep Bio-active Peptides Product and Services
Table 16. Phermpep Bio-active Peptides Sales Quantity (Ton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Phermpep Recent Developments/Updates
Table 18. Arlak Biotech Basic Information, Manufacturing Base and Competitors
Table 19. Arlak Biotech Major Business
Table 20. Arlak Biotech Bio-active Peptides Product and Services
Table 21. Arlak Biotech Bio-active Peptides Sales Quantity (Ton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Arlak Biotech Recent Developments/Updates
Table 23. Naturade Basic Information, Manufacturing Base and Competitors
Table 24. Naturade Major Business
Table 25. Naturade Bio-active Peptides Product and Services
Table 26. Naturade Bio-active Peptides Sales Quantity (Ton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Naturade Recent Developments/Updates
Table 28. Royal DSM Basic Information, Manufacturing Base and Competitors
Table 29. Royal DSM Major Business
Table 30. Royal DSM Bio-active Peptides Product and Services
Table 31. Royal DSM Bio-active Peptides Sales Quantity (Ton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Royal DSM Recent Developments/Updates
Table 33. MYOS RENS Technology Basic Information, Manufacturing Base and Competitors
Table 34. MYOS RENS Technology Major Business
Table 35. MYOS RENS Technology Bio-active Peptides Product and Services
Table 36. MYOS RENS Technology Bio-active Peptides Sales Quantity (Ton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. MYOS RENS Technology Recent Developments/Updates
Table 38. Natural Factors Nutritional Products Basic Information, Manufacturing Base and Competitors
Table 39. Natural Factors Nutritional Products Major Business
Table 40. Natural Factors Nutritional Products Bio-active Peptides Product and Services
Table 41. Natural Factors Nutritional Products Bio-active Peptides Sales Quantity (Ton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Natural Factors Nutritional Products Recent Developments/Updates
Table 43. Valio Oy Basic Information, Manufacturing Base and Competitors
Table 44. Valio Oy Major Business
Table 45. Valio Oy Bio-active Peptides Product and Services
Table 46. Valio Oy Bio-active Peptides Sales Quantity (Ton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Valio Oy Recent Developments/Updates
Table 48. Wuhan Lullaby Pharmaceutical Chemical Basic Information, Manufacturing Base and Competitors
Table 49. Wuhan Lullaby Pharmaceutical Chemical Major Business
Table 50. Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Product and Services
Table 51. Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Sales Quantity (Ton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Wuhan Lullaby Pharmaceutical Chemical Recent Developments/Updates
Table 53. Wuhan Dahua Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Wuhan Dahua Pharmaceutical Major Business
Table 55. Wuhan Dahua Pharmaceutical Bio-active Peptides Product and Services
Table 56. Wuhan Dahua Pharmaceutical Bio-active Peptides Sales Quantity (Ton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Wuhan Dahua Pharmaceutical Recent Developments/Updates
Table 58. Pharma Foods International Basic Information, Manufacturing Base and Competitors
Table 59. Pharma Foods International Major Business
Table 60. Pharma Foods International Bio-active Peptides Product and Services
Table 61. Pharma Foods International Bio-active Peptides Sales Quantity (Ton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Pharma Foods International Recent Developments/Updates
Table 63. Global Bio-active Peptides Sales Quantity by Manufacturer (2018-2023) & (Ton)
Table 64. Global Bio-active Peptides Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Bio-active Peptides Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 66. Market Position of Manufacturers in Bio-active Peptides, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Bio-active Peptides Production Site of Key Manufacturer
Table 68. Bio-active Peptides Market: Company Product Type Footprint
Table 69. Bio-active Peptides Market: Company Product Application Footprint
Table 70. Bio-active Peptides New Market Entrants and Barriers to Market Entry
Table 71. Bio-active Peptides Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Bio-active Peptides Sales Quantity by Region (2018-2023) & (Ton)
Table 73. Global Bio-active Peptides Sales Quantity by Region (2024-2029) & (Ton)
Table 74. Global Bio-active Peptides Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Bio-active Peptides Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Bio-active Peptides Average Price by Region (2018-2023) & (US$/Ton)
Table 77. Global Bio-active Peptides Average Price by Region (2024-2029) & (US$/Ton)
Table 78. Global Bio-active Peptides Sales Quantity by Type (2018-2023) & (Ton)
Table 79. Global Bio-active Peptides Sales Quantity by Type (2024-2029) & (Ton)
Table 80. Global Bio-active Peptides Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Bio-active Peptides Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Bio-active Peptides Average Price by Type (2018-2023) & (US$/Ton)
Table 83. Global Bio-active Peptides Average Price by Type (2024-2029) & (US$/Ton)
Table 84. Global Bio-active Peptides Sales Quantity by Application (2018-2023) & (Ton)
Table 85. Global Bio-active Peptides Sales Quantity by Application (2024-2029) & (Ton)
Table 86. Global Bio-active Peptides Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Bio-active Peptides Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Bio-active Peptides Average Price by Application (2018-2023) & (US$/Ton)
Table 89. Global Bio-active Peptides Average Price by Application (2024-2029) & (US$/Ton)
Table 90. North America Bio-active Peptides Sales Quantity by Type (2018-2023) & (Ton)
Table 91. North America Bio-active Peptides Sales Quantity by Type (2024-2029) & (Ton)
Table 92. North America Bio-active Peptides Sales Quantity by Application (2018-2023) & (Ton)
Table 93. North America Bio-active Peptides Sales Quantity by Application (2024-2029) & (Ton)
Table 94. North America Bio-active Peptides Sales Quantity by Country (2018-2023) & (Ton)
Table 95. North America Bio-active Peptides Sales Quantity by Country (2024-2029) & (Ton)
Table 96. North America Bio-active Peptides Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Bio-active Peptides Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Bio-active Peptides Sales Quantity by Type (2018-2023) & (Ton)
Table 99. Europe Bio-active Peptides Sales Quantity by Type (2024-2029) & (Ton)
Table 100. Europe Bio-active Peptides Sales Quantity by Application (2018-2023) & (Ton)
Table 101. Europe Bio-active Peptides Sales Quantity by Application (2024-2029) & (Ton)
Table 102. Europe Bio-active Peptides Sales Quantity by Country (2018-2023) & (Ton)
Table 103. Europe Bio-active Peptides Sales Quantity by Country (2024-2029) & (Ton)
Table 104. Europe Bio-active Peptides Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Bio-active Peptides Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Bio-active Peptides Sales Quantity by Type (2018-2023) & (Ton)
Table 107. Asia-Pacific Bio-active Peptides Sales Quantity by Type (2024-2029) & (Ton)
Table 108. Asia-Pacific Bio-active Peptides Sales Quantity by Application (2018-2023) & (Ton)
Table 109. Asia-Pacific Bio-active Peptides Sales Quantity by Application (2024-2029) & (Ton)
Table 110. Asia-Pacific Bio-active Peptides Sales Quantity by Region (2018-2023) & (Ton)
Table 111. Asia-Pacific Bio-active Peptides Sales Quantity by Region (2024-2029) & (Ton)
Table 112. Asia-Pacific Bio-active Peptides Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Bio-active Peptides Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Bio-active Peptides Sales Quantity by Type (2018-2023) & (Ton)
Table 115. South America Bio-active Peptides Sales Quantity by Type (2024-2029) & (Ton)
Table 116. South America Bio-active Peptides Sales Quantity by Application (2018-2023) & (Ton)
Table 117. South America Bio-active Peptides Sales Quantity by Application (2024-2029) & (Ton)
Table 118. South America Bio-active Peptides Sales Quantity by Country (2018-2023) & (Ton)
Table 119. South America Bio-active Peptides Sales Quantity by Country (2024-2029) & (Ton)
Table 120. South America Bio-active Peptides Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Bio-active Peptides Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Bio-active Peptides Sales Quantity by Type (2018-2023) & (Ton)
Table 123. Middle East & Africa Bio-active Peptides Sales Quantity by Type (2024-2029) & (Ton)
Table 124. Middle East & Africa Bio-active Peptides Sales Quantity by Application (2018-2023) & (Ton)
Table 125. Middle East & Africa Bio-active Peptides Sales Quantity by Application (2024-2029) & (Ton)
Table 126. Middle East & Africa Bio-active Peptides Sales Quantity by Region (2018-2023) & (Ton)
Table 127. Middle East & Africa Bio-active Peptides Sales Quantity by Region (2024-2029) & (Ton)
Table 128. Middle East & Africa Bio-active Peptides Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Bio-active Peptides Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Bio-active Peptides Raw Material
Table 131. Key Manufacturers of Bio-active Peptides Raw Materials
Table 132. Bio-active Peptides Typical Distributors
Table 133. Bio-active Peptides Typical Customers
Table 1. Global Bio-active Peptides Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Bio-active Peptides Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Archer Daniels Midland Company Basic Information, Manufacturing Base and Competitors
Table 4. Archer Daniels Midland Company Major Business
Table 5. Archer Daniels Midland Company Bio-active Peptides Product and Services
Table 6. Archer Daniels Midland Company Bio-active Peptides Sales Quantity (Ton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Archer Daniels Midland Company Recent Developments/Updates
Table 8. Seagarden AS Basic Information, Manufacturing Base and Competitors
Table 9. Seagarden AS Major Business
Table 10. Seagarden AS Bio-active Peptides Product and Services
Table 11. Seagarden AS Bio-active Peptides Sales Quantity (Ton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Seagarden AS Recent Developments/Updates
Table 13. Phermpep Basic Information, Manufacturing Base and Competitors
Table 14. Phermpep Major Business
Table 15. Phermpep Bio-active Peptides Product and Services
Table 16. Phermpep Bio-active Peptides Sales Quantity (Ton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Phermpep Recent Developments/Updates
Table 18. Arlak Biotech Basic Information, Manufacturing Base and Competitors
Table 19. Arlak Biotech Major Business
Table 20. Arlak Biotech Bio-active Peptides Product and Services
Table 21. Arlak Biotech Bio-active Peptides Sales Quantity (Ton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Arlak Biotech Recent Developments/Updates
Table 23. Naturade Basic Information, Manufacturing Base and Competitors
Table 24. Naturade Major Business
Table 25. Naturade Bio-active Peptides Product and Services
Table 26. Naturade Bio-active Peptides Sales Quantity (Ton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Naturade Recent Developments/Updates
Table 28. Royal DSM Basic Information, Manufacturing Base and Competitors
Table 29. Royal DSM Major Business
Table 30. Royal DSM Bio-active Peptides Product and Services
Table 31. Royal DSM Bio-active Peptides Sales Quantity (Ton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Royal DSM Recent Developments/Updates
Table 33. MYOS RENS Technology Basic Information, Manufacturing Base and Competitors
Table 34. MYOS RENS Technology Major Business
Table 35. MYOS RENS Technology Bio-active Peptides Product and Services
Table 36. MYOS RENS Technology Bio-active Peptides Sales Quantity (Ton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. MYOS RENS Technology Recent Developments/Updates
Table 38. Natural Factors Nutritional Products Basic Information, Manufacturing Base and Competitors
Table 39. Natural Factors Nutritional Products Major Business
Table 40. Natural Factors Nutritional Products Bio-active Peptides Product and Services
Table 41. Natural Factors Nutritional Products Bio-active Peptides Sales Quantity (Ton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Natural Factors Nutritional Products Recent Developments/Updates
Table 43. Valio Oy Basic Information, Manufacturing Base and Competitors
Table 44. Valio Oy Major Business
Table 45. Valio Oy Bio-active Peptides Product and Services
Table 46. Valio Oy Bio-active Peptides Sales Quantity (Ton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Valio Oy Recent Developments/Updates
Table 48. Wuhan Lullaby Pharmaceutical Chemical Basic Information, Manufacturing Base and Competitors
Table 49. Wuhan Lullaby Pharmaceutical Chemical Major Business
Table 50. Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Product and Services
Table 51. Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Sales Quantity (Ton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Wuhan Lullaby Pharmaceutical Chemical Recent Developments/Updates
Table 53. Wuhan Dahua Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Wuhan Dahua Pharmaceutical Major Business
Table 55. Wuhan Dahua Pharmaceutical Bio-active Peptides Product and Services
Table 56. Wuhan Dahua Pharmaceutical Bio-active Peptides Sales Quantity (Ton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Wuhan Dahua Pharmaceutical Recent Developments/Updates
Table 58. Pharma Foods International Basic Information, Manufacturing Base and Competitors
Table 59. Pharma Foods International Major Business
Table 60. Pharma Foods International Bio-active Peptides Product and Services
Table 61. Pharma Foods International Bio-active Peptides Sales Quantity (Ton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Pharma Foods International Recent Developments/Updates
Table 63. Global Bio-active Peptides Sales Quantity by Manufacturer (2018-2023) & (Ton)
Table 64. Global Bio-active Peptides Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Bio-active Peptides Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 66. Market Position of Manufacturers in Bio-active Peptides, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Bio-active Peptides Production Site of Key Manufacturer
Table 68. Bio-active Peptides Market: Company Product Type Footprint
Table 69. Bio-active Peptides Market: Company Product Application Footprint
Table 70. Bio-active Peptides New Market Entrants and Barriers to Market Entry
Table 71. Bio-active Peptides Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Bio-active Peptides Sales Quantity by Region (2018-2023) & (Ton)
Table 73. Global Bio-active Peptides Sales Quantity by Region (2024-2029) & (Ton)
Table 74. Global Bio-active Peptides Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Bio-active Peptides Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Bio-active Peptides Average Price by Region (2018-2023) & (US$/Ton)
Table 77. Global Bio-active Peptides Average Price by Region (2024-2029) & (US$/Ton)
Table 78. Global Bio-active Peptides Sales Quantity by Type (2018-2023) & (Ton)
Table 79. Global Bio-active Peptides Sales Quantity by Type (2024-2029) & (Ton)
Table 80. Global Bio-active Peptides Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Bio-active Peptides Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Bio-active Peptides Average Price by Type (2018-2023) & (US$/Ton)
Table 83. Global Bio-active Peptides Average Price by Type (2024-2029) & (US$/Ton)
Table 84. Global Bio-active Peptides Sales Quantity by Application (2018-2023) & (Ton)
Table 85. Global Bio-active Peptides Sales Quantity by Application (2024-2029) & (Ton)
Table 86. Global Bio-active Peptides Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Bio-active Peptides Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Bio-active Peptides Average Price by Application (2018-2023) & (US$/Ton)
Table 89. Global Bio-active Peptides Average Price by Application (2024-2029) & (US$/Ton)
Table 90. North America Bio-active Peptides Sales Quantity by Type (2018-2023) & (Ton)
Table 91. North America Bio-active Peptides Sales Quantity by Type (2024-2029) & (Ton)
Table 92. North America Bio-active Peptides Sales Quantity by Application (2018-2023) & (Ton)
Table 93. North America Bio-active Peptides Sales Quantity by Application (2024-2029) & (Ton)
Table 94. North America Bio-active Peptides Sales Quantity by Country (2018-2023) & (Ton)
Table 95. North America Bio-active Peptides Sales Quantity by Country (2024-2029) & (Ton)
Table 96. North America Bio-active Peptides Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Bio-active Peptides Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Bio-active Peptides Sales Quantity by Type (2018-2023) & (Ton)
Table 99. Europe Bio-active Peptides Sales Quantity by Type (2024-2029) & (Ton)
Table 100. Europe Bio-active Peptides Sales Quantity by Application (2018-2023) & (Ton)
Table 101. Europe Bio-active Peptides Sales Quantity by Application (2024-2029) & (Ton)
Table 102. Europe Bio-active Peptides Sales Quantity by Country (2018-2023) & (Ton)
Table 103. Europe Bio-active Peptides Sales Quantity by Country (2024-2029) & (Ton)
Table 104. Europe Bio-active Peptides Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Bio-active Peptides Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Bio-active Peptides Sales Quantity by Type (2018-2023) & (Ton)
Table 107. Asia-Pacific Bio-active Peptides Sales Quantity by Type (2024-2029) & (Ton)
Table 108. Asia-Pacific Bio-active Peptides Sales Quantity by Application (2018-2023) & (Ton)
Table 109. Asia-Pacific Bio-active Peptides Sales Quantity by Application (2024-2029) & (Ton)
Table 110. Asia-Pacific Bio-active Peptides Sales Quantity by Region (2018-2023) & (Ton)
Table 111. Asia-Pacific Bio-active Peptides Sales Quantity by Region (2024-2029) & (Ton)
Table 112. Asia-Pacific Bio-active Peptides Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Bio-active Peptides Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Bio-active Peptides Sales Quantity by Type (2018-2023) & (Ton)
Table 115. South America Bio-active Peptides Sales Quantity by Type (2024-2029) & (Ton)
Table 116. South America Bio-active Peptides Sales Quantity by Application (2018-2023) & (Ton)
Table 117. South America Bio-active Peptides Sales Quantity by Application (2024-2029) & (Ton)
Table 118. South America Bio-active Peptides Sales Quantity by Country (2018-2023) & (Ton)
Table 119. South America Bio-active Peptides Sales Quantity by Country (2024-2029) & (Ton)
Table 120. South America Bio-active Peptides Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Bio-active Peptides Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Bio-active Peptides Sales Quantity by Type (2018-2023) & (Ton)
Table 123. Middle East & Africa Bio-active Peptides Sales Quantity by Type (2024-2029) & (Ton)
Table 124. Middle East & Africa Bio-active Peptides Sales Quantity by Application (2018-2023) & (Ton)
Table 125. Middle East & Africa Bio-active Peptides Sales Quantity by Application (2024-2029) & (Ton)
Table 126. Middle East & Africa Bio-active Peptides Sales Quantity by Region (2018-2023) & (Ton)
Table 127. Middle East & Africa Bio-active Peptides Sales Quantity by Region (2024-2029) & (Ton)
Table 128. Middle East & Africa Bio-active Peptides Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Bio-active Peptides Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Bio-active Peptides Raw Material
Table 131. Key Manufacturers of Bio-active Peptides Raw Materials
Table 132. Bio-active Peptides Typical Distributors
Table 133. Bio-active Peptides Typical Customers
LIST OF FIGURES
Figure 1. Bio-active Peptides Picture
Figure 2. Global Bio-active Peptides Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Bio-active Peptides Consumption Value Market Share by Type in 2022
Figure 4. Natural Bio-active Peptides Examples
Figure 5. Artificial Synthesis Bio-active Peptides Examples
Figure 6. Global Bio-active Peptides Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Bio-active Peptides Consumption Value Market Share by Application in 2022
Figure 8. Food Examples
Figure 9. Health Products Examples
Figure 10. Pharmaceutical Examples
Figure 11. Other Examples
Figure 12. Global Bio-active Peptides Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Bio-active Peptides Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Bio-active Peptides Sales Quantity (2018-2029) & (Ton)
Figure 15. Global Bio-active Peptides Average Price (2018-2029) & (US$/Ton)
Figure 16. Global Bio-active Peptides Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Bio-active Peptides Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Bio-active Peptides by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Bio-active Peptides Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Bio-active Peptides Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Bio-active Peptides Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Bio-active Peptides Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Bio-active Peptides Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Bio-active Peptides Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Bio-active Peptides Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Bio-active Peptides Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Bio-active Peptides Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Bio-active Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Bio-active Peptides Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Bio-active Peptides Average Price by Type (2018-2029) & (US$/Ton)
Figure 31. Global Bio-active Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Bio-active Peptides Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Bio-active Peptides Average Price by Application (2018-2029) & (US$/Ton)
Figure 34. North America Bio-active Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Bio-active Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Bio-active Peptides Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Bio-active Peptides Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Bio-active Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Bio-active Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Bio-active Peptides Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Bio-active Peptides Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Bio-active Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Bio-active Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Bio-active Peptides Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Bio-active Peptides Consumption Value Market Share by Region (2018-2029)
Figure 54. China Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Bio-active Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Bio-active Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Bio-active Peptides Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Bio-active Peptides Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Bio-active Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Bio-active Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Bio-active Peptides Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Bio-active Peptides Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Bio-active Peptides Market Drivers
Figure 75. Bio-active Peptides Market Restraints
Figure 76. Bio-active Peptides Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Bio-active Peptides in 2022
Figure 79. Manufacturing Process Analysis of Bio-active Peptides
Figure 80. Bio-active Peptides Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Bio-active Peptides Picture
Figure 2. Global Bio-active Peptides Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Bio-active Peptides Consumption Value Market Share by Type in 2022
Figure 4. Natural Bio-active Peptides Examples
Figure 5. Artificial Synthesis Bio-active Peptides Examples
Figure 6. Global Bio-active Peptides Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Bio-active Peptides Consumption Value Market Share by Application in 2022
Figure 8. Food Examples
Figure 9. Health Products Examples
Figure 10. Pharmaceutical Examples
Figure 11. Other Examples
Figure 12. Global Bio-active Peptides Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Bio-active Peptides Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Bio-active Peptides Sales Quantity (2018-2029) & (Ton)
Figure 15. Global Bio-active Peptides Average Price (2018-2029) & (US$/Ton)
Figure 16. Global Bio-active Peptides Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Bio-active Peptides Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Bio-active Peptides by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Bio-active Peptides Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Bio-active Peptides Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Bio-active Peptides Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Bio-active Peptides Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Bio-active Peptides Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Bio-active Peptides Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Bio-active Peptides Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Bio-active Peptides Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Bio-active Peptides Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Bio-active Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Bio-active Peptides Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Bio-active Peptides Average Price by Type (2018-2029) & (US$/Ton)
Figure 31. Global Bio-active Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Bio-active Peptides Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Bio-active Peptides Average Price by Application (2018-2029) & (US$/Ton)
Figure 34. North America Bio-active Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Bio-active Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Bio-active Peptides Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Bio-active Peptides Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Bio-active Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Bio-active Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Bio-active Peptides Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Bio-active Peptides Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Bio-active Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Bio-active Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Bio-active Peptides Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Bio-active Peptides Consumption Value Market Share by Region (2018-2029)
Figure 54. China Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Bio-active Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Bio-active Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Bio-active Peptides Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Bio-active Peptides Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Bio-active Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Bio-active Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Bio-active Peptides Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Bio-active Peptides Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Bio-active Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Bio-active Peptides Market Drivers
Figure 75. Bio-active Peptides Market Restraints
Figure 76. Bio-active Peptides Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Bio-active Peptides in 2022
Figure 79. Manufacturing Process Analysis of Bio-active Peptides
Figure 80. Bio-active Peptides Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
